Evidence map›Paper›PMID 41718485›Full record

ArticleAntimicrobial agents and chemotherapy2026

A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin.

Yinyue Li, Shuang Li, Huajun Li, Yun Yang, Jiahui Xu, Ying Deng, Xinlong He, Fang Tian, Jin-Hee Han, Eun-Taek Han and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yinyue Li *School of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Shuang Li *School of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Huajun LiSchool of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
Yun YangSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Jiahui XuSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Ying DengSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Xinlong HeSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Fang TianSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Jin-Hee HanDepartment of Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea.
Eun-Taek HanDepartment of Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea.
Juqun XiSchool of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
Feng LuSchool of Basic Medical Sciences, Faculty of Medicine, Yangzhou University, Yangzhou, China.ORCID 0000-0002-9599-3716

Funding

National Natural Science Foundation of China 82072297, 82572607
6 · The paper itself

Abstract

While malaria parasites rely on labile Fe

Indexed as

AntimalarialsArtemisininsIronPlasmodium falciparumAnimalsBioreactorsDrug ResistanceMalariaMiceNanoparticlesPlasmodium bergheiReactive Oxygen SpeciesAntimalarialsartemisininArtemisininsIronReactive Oxygen Speciesartemisinin (ART)ART-resistant malaria parasitesFe2+malariaPDA@Fe/P

Identifiers

PMID41718485
PMCPMC13041302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.